DiaCarta, Inc. serves as a leading diagnostic center located in Pleasanton, California, specializing in translational genomics and precision molecular diagnostics. Established in 2011, the company focuses on enhancing healthcare treatment plans through advanced technologies. With over 80 global patents, DiaCarta offers a comprehensive range of products and services designed to improve patient outcomes.
The diagnostic services include single-gene cancer mutation detection qPCR assays and colorectal cancer mutation detection panels. Additionally, DiaCarta provides radiation therapy toxicity monitoring through cfDNA tests and targeted NGS panels. These offerings cater to the evolving needs of healthcare professionals and patients, ensuring accurate and timely diagnostic results.
DiaCarta’s commitment to innovation and quality sets it apart within the diagnostics field. The company's advanced technologies are designed to provide highly sensitive results that aid in personalized treatment strategies. This focus on precision molecular diagnostics ensures that healthcare providers can make informed decisions based on reliable data.
With a strong foundation in research and development, DiaCarta continues to expand its capabilities and product offerings. The company’s dedication to improving health outcomes resonates throughout the medical community. DiaCarta stands ready to support healthcare professionals with its cutting-edge diagnostic solutions. Explore the benefits of DiaCarta’s services today by visiting their location in Pleasanton, California.
